Miriam Ivenshitz

Miriam joined Clear-Cut at the beginning of 2020, bringing with her more than a decade of clinical and regulatory experience in the medical device field with a proven track record of FDA, PMDA and CE market clearances. Miriam held VP Clinical & Regulatory roles at Israeli companies in the cardiovascular space including CathWorks, a company focused on non-invasive FFR technologies for cardiac PCI decision-making, where she was in charge of clinical activity through successful 510(k) clearance of the device, and InspireMD, a company focused on coronary and carotid stenting, where she managed large scale RCTs. Miriam holds a Ph.D. in Neurosciences from the Weizmann Institute of Science and completed Post Doctorate studies in cardiac development.